MedTrace Logo

ENB-guided Ablation Therapy Combined With VATS in the Treatment of MPLC

NCT04730453 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 30

Last updated 2021-01-29

No results posted yet for this study

Summary

The study is designed as a prospective trial whose purpose is to evaluate the effectiveness and safety of ENB-guided ablation therapy combined with VATS in the treatment of multiple primary lung cancers (MPLC).

Conditions

Interventions

PROCEDURE

ENB-guided ablation therapy combined with VATS

After receiving multidisciplinary assessments, Lesion A will receive ENB-guided ablation therapy and Lesion B will receive VATS at the same time.

Sponsors & Collaborators

  • Shanghai Chest Hospital

    lead OTHER

Principal Investigators

  • Jiayuan Sun, MD, PhD · Shanghai Chest Hospital

Eligibility

Min Age
18 Minutes
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-07-24
Primary Completion
2025-01-31
Completion
2025-12-31

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04730453 on ClinicalTrials.gov